The deadly disease of lung cancer occurs when the cells in lung grow uncontrollably and form a mass called as tumor. This lung cancer can begin anywhere in the lung and once…
Tag: Lung Cancer Awareness
Researchers Find Potential Marker for Success in Immunotherapy in Lung Cancer Patients
Lung Cancer has the highest mortality rate of all cancer and smoking remains the main cause behind this deadly disease. As far as the treatment options for lung cancer are considered, there…
Study: Lung Cancer Patients Can Be Screened For MET Oncogene
The researchers at Mayo Clinic Cancer Center have conducted a research and their findings are published in Cancer Discovery, a journal of American Association for Cancer Research. Their research suggests that physicians…
Research Shows How Circadian Regulation Affects Glucose Production during Lung Cancer Progression
A new research from the University of California, Irvine has revealed that loss of circadian regulation allows for increase in glucose production as lung cancer progresses. The study is titled “Glucagon regulates…
What is Combination Therapy for Metastatic Lung Cancer?
Most of the times, lung cancer is found when it has already spread to other parts of the body. It may have travel to lymph nodes near or away from lung, the…
Managing Shortness of Breath among Lung Cancer Patients
Shortness of breath, also called dyspnea, is common with lung cancer patients and it often gets worse with advancement of disease. This trouble in breathing may be caused by growth of tumor,…
Study Suggests, Not to Delay Lung Cancer Surgery
According to a new study by researchers at Washington University School of Medicine in St. Louis, delaying lung cancer surgery for more than 12 weeks from the date of diagnosis with CT…
FDA Approves First Targeted Therapy for Lung Cancer with Specific Genetic Mutation
The U.S. Food and Drug Administration has approved Lumakras (sotorasib) as first treatment for non-small cell lung cancer patients whose tumors have specific type of genetic mutation called KRAS G12C. It is…
FDA Approves Rybrevant for Certain Patients with Non-Small Cell Lung Cancer
Lung cancer is a complex disease, accounting for almost 25% of all cancer deaths. The Food and Drug Administration (FDA) has approved Rybrevant for treatment of adults with non-small cell lung cancer…
Study: New Breath Test to Detect Lung Cancer
Lung cancer is the second most commonly diagnosed cancers. According to the World Health Organization, there were 2.2 million new lung cancer cases and 1.8 million people died from the disease in…
Genetic Testing for Lung Cancer – Why is It Important?
Genetic mutations play an important role in the development of lung cancer. Genetic testing helps in identifying specific genetic changes in the tumor cells that might be get treated with targeted therapies….
Asbestos and Lung Cancer – What’s The Link?
Asbestos refers to the group of minerals occurring naturally as bundles of fibers. It has largely been used to insulate buildings like homes, buildings etc. These mineral fibers were widely used for…